Results 171 to 180 of about 1,819,855 (334)

Management of Respiratory Distress of Infant

, 1969
Yoshihisa Nagoshi
openalex   +2 more sources

1031 RISK OF RESPIRATORY DISTRESS SYNDROME AND MATERNAL INFECTION AFTER PRENATAL DEXAMETHASONE TREATMENT [PDF]

, 1978
H. William Taeusch, F D Frigoletto, John L. Kitzmiller, Mary Ellen Avery, Ann Hehre, Barbara S. Fromm, Edward E. Lawson, R K Neff   +7 more
openalex   +1 more source

Cardiogenic shock requiring VA‐ECMO therapy in scorpionism‐induced myocarditis

ESC Heart Failure, EarlyView.
Alba I. Violino, María Alicia Lozano, Rocio Garcia Moralez, Juan P. Ricarte‐Bratti, Julieta Lozita, Elizabeth Y. Ravinovich   +5 more
wiley   +1 more source

Kaempferol Alleviates Acrolein‐Induced Lung Injury In Vitro and In Vivo by Binding to Peli2 and Disrupting the Peli2‐NLRP3 Interaction

Food Frontiers, EarlyView.
Abstract Acrolein (ACR) is a highly toxic agent that induces lung inflammation and causes acute lung injury (ALI). However, effective treatments for ACR‐induced ALI are currently lacking. We investigated the protective effects of kaempferol (Kae) against ACR‐induced ALI using in vitro (HBE and BEAS‐2B cells) and in vivo murine models (male C57BL/6 mice)
Juanjuan Ma, Zhao Yin, Jie Zheng, Xingyou Mo, Shaoji Li, Hua Liu, Shiyi Ou   +6 more
wiley   +1 more source

Application of metabolomics in acute respiratory distress syndrome: A narrative review. [PDF]

Sci Prog
Song XY, Qin H, Zhang W.
europepmc   +1 more source

COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

The Lancet Respiratory Medicine, 2020
E. Fan, J. Beitler, L. Brochard, C. Calfee, N. Ferguson, Arthur S Slutsky, D. Brodie   +6 more
semanticscholar   +1 more source

Red cell volume in respiratory distress syndrome [PDF]

, 1971
R. Usher, Saroj Saigal, Allison F. O’Neill, Le-Beng Chua, Y. A. Surainder   +4 more
openalex   +1 more source

Medication, Nutrition, and Hygiene in COVID‐19 Prevention and Treatment: A Comprehensive Narrative Review

Global Challenges, EarlyView.
This narrative review presents evidence from 2020 to 2025 on antiviral medications, adjunctive therapies, and nutritional interventions for COVID‐19. It highlights the roles of remdesivir, monupiravir, nirmatrelvir/ritonavir, corticosteroids, vitamins, and hygiene practices, emphasizing an integrated approach that combines pharmacologic treatments ...
Wan‐Ting Kuo, I‐Hsiu Lai
wiley   +1 more source

Identification of mitochondria-related biomarkers for acute respiratory distress syndrome. [PDF]

Sci Rep
Hongyuan H, Mengchi C, Yingying L, Xiaowen Z, Qiaojuan H, Jianghua L.   +5 more
europepmc   +1 more source

Respiratory Distress Syndrome [PDF]

BMJ, 1967
M. E. Stoneman, M. Reid, R. M. Owens
openaire   +2 more sources